Search research articles
Contact Us
Filters
Showing results (121-130 of 139) with videos related to
Page
of 14
Sort By:
The Journal of Clinical Endocrinology and Metabolism
|
February 26, 2000
Detection of minimal levels of serum anti-Müllerian hormone during follow-up of patients with ovarian granulosa cell tumor by means of a highly sensitive enzyme-linked immunosorbent assay
W Q Long, V Ranchin, P Pautier, et al.
The Journal of Clinical Endocrinology and Metabolism
|
September 1, 1997
Identification of pro-EPIL and EPIL peptides translated from insulin-like 4 (INSL4) mRNA in human placenta
D Bellet, L Lavaissiere, P Mock, et al.
Endocrinology
|
July 1, 1984
A monoclonal antibody against a synthetic peptide is specific for the free native human chorionic gonadotropin beta-subunit
D Bellet, J M Bidart, M Jolivet, et al.
The Journal of Urology
|
February 18, 1999
Hormone-refractory prostate cancer cells express functional follicle-stimulating hormone receptor (FSHR)
E Ben-Josef, S Y Yang, T H Ji, et al.
Annales D'Endocrinologie
|
January 1, 1984
[Monoclonal antibodies directed against the beta hCG subunit and against a synthetic peptide analog of the carboxyl-terminal end. Clinical use in vivo and in vitro]
D Bellet, M Ozturk, J M Bidart, et al.
Bulletin Du Cancer
|
October 2, 2001
[Standards, options and recommendations for blood tumor markers in thyroid cancers]
M F Pichon, J P Basuyau, G Gory-Delabaere, et al.
British Journal of Cancer
|
October 29, 1998
Neuron-specific enolase and chromogranin A as markers of neuroendocrine tumours
E Baudin, A Gigliotti, M Ducreux, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 1, 1985
Drug-induced antibodies during 2-N-methyl-9-hydroxyellipticinium acetate (NSC-264137) treatment: schedule dependency and relationship to hemolysis
J M Mondesir, J M Bidart, A Goodman, et al.
Bulletin Du Cancer
|
November 21, 2000
[Standards, Options and Recommendations (SOR) for tumor markers in breast cancer. SOR Working Group]
J P Basuyau, M P Blanc-Vincent, J M Bidart, et al.
Endocrine-Related Cancer
|
December 2, 2010
Do histological, immunohistochemical, and metabolic (radioiodine and fluorodeoxyglucose uptakes) patterns of metastatic thyroid cancer correlate with patient outcome?
D Deandreis, A Al Ghuzlan, S Leboulleux, et al.
Page
of 14
Search research articles
Search
Showing results (121-130 of 139) with videos related to
Sort By:
Page
of 14
The Journal of Clinical Endocrinology and Metabolism
|
February 26, 2000
Detection of minimal levels of serum anti-Müllerian hormone during follow-up of patients with ovarian granulosa cell tumor by means of a highly sensitive enzyme-linked immunosorbent assay
W Q Long, V Ranchin, P Pautier, et al.
The Journal of Clinical Endocrinology and Metabolism
|
September 1, 1997
Identification of pro-EPIL and EPIL peptides translated from insulin-like 4 (INSL4) mRNA in human placenta
D Bellet, L Lavaissiere, P Mock, et al.
Endocrinology
|
July 1, 1984
A monoclonal antibody against a synthetic peptide is specific for the free native human chorionic gonadotropin beta-subunit
D Bellet, J M Bidart, M Jolivet, et al.
The Journal of Urology
|
February 18, 1999
Hormone-refractory prostate cancer cells express functional follicle-stimulating hormone receptor (FSHR)
E Ben-Josef, S Y Yang, T H Ji, et al.
Annales D'Endocrinologie
|
January 1, 1984
[Monoclonal antibodies directed against the beta hCG subunit and against a synthetic peptide analog of the carboxyl-terminal end. Clinical use in vivo and in vitro]
D Bellet, M Ozturk, J M Bidart, et al.
Bulletin Du Cancer
|
October 2, 2001
[Standards, options and recommendations for blood tumor markers in thyroid cancers]
M F Pichon, J P Basuyau, G Gory-Delabaere, et al.
British Journal of Cancer
|
October 29, 1998
Neuron-specific enolase and chromogranin A as markers of neuroendocrine tumours
E Baudin, A Gigliotti, M Ducreux, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 1, 1985
Drug-induced antibodies during 2-N-methyl-9-hydroxyellipticinium acetate (NSC-264137) treatment: schedule dependency and relationship to hemolysis
J M Mondesir, J M Bidart, A Goodman, et al.
Bulletin Du Cancer
|
November 21, 2000
[Standards, Options and Recommendations (SOR) for tumor markers in breast cancer. SOR Working Group]
J P Basuyau, M P Blanc-Vincent, J M Bidart, et al.
Endocrine-Related Cancer
|
December 2, 2010
Do histological, immunohistochemical, and metabolic (radioiodine and fluorodeoxyglucose uptakes) patterns of metastatic thyroid cancer correlate with patient outcome?
D Deandreis, A Al Ghuzlan, S Leboulleux, et al.
Page
of 14